Oligomycin A enhances apoptotic effect of TRAIL through CHOP-mediated death receptor 5 expression

Long He, Jae Hyuk Jang, Hyun Gil Choi, Sun Mi Lee, Mei Hua Nan, Sook Jung Jeong, Zigang Dong, Yong Tae Kwon, Kyung Sang Lee, Ki Won Lee, Jong Kyeong Chung, Jong Seog Ahn, Bo Yeon Kim

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


Development of resistance to TNF-related apoptosis-inducing ligand (TRAIL) in tumor cells is one of the important problems in cancer treatment. Despite the previous report demonstrating that oligomycin suppressed TNF-induced apoptosis, in our screening of small molecules enhancing cancer cell death to TRAIL, oligomycin A (OMA) was found to enhance TRAIL-induced apoptosis in HeLa cells. CCAAT/enhancer-binding protein homologous protein (CHOP) was found to directly bind to death receptor 5 (DR5) promoter through endoplasmic reticulum stress (ER-stress) signaling and sensitize the cells to TRAIL. Among ER-stress associated proteins, OMA triggered the inositol-requiring enzyme 1 (IRE1) signaling pathway, leading to X-binding protein 1 (XBP1) splicing, CHOP expression and DR5 upregulation. In contrast, small-interfering RNA (siRNA) of CHOP reduced the number of apoptotic cells in response to the co-treatment of TRAIL and OMA. Collectively, our data suggest that OMA enhances apoptotic death of cervical cancer cells to TRAIL through upregulation of CHOP-mediated DR5 expression following ER-stress.

Original languageEnglish (US)
Pages (from-to)85-93
Number of pages9
JournalMolecular Carcinogenesis
Issue number2
StatePublished - Feb 2013


  • CHOP
  • Chemosensitization
  • DR5
  • Oligomycin A


Dive into the research topics of 'Oligomycin A enhances apoptotic effect of TRAIL through CHOP-mediated death receptor 5 expression'. Together they form a unique fingerprint.

Cite this